Professional Education
Alzheimer's 5 : Use of Pharmacotherapy for Patients with Major Neurocognitive Disorder
This activity includes video lectures and is the fifth in a series of courses that seek to educate clinicians on standardized screening, evaluation, and disease management of Alzheimer's disease and related dementias. This fifth course focuses on the most frequently used and FDA-approved prescription medications for Alzheimer's disease and dementias, the current research regarding its use, and guidelines for prescribing and discontinuing medication. The program will incorporate cultural values and beliefs when creating and sharing the pharmacological care plan. [1.75 AMA PRA Category 1 Credits™, 1.75 Contact Hours (ANCC)]
Search
April 22, 2024, Part B News
Measles in Your Office? Follow CDC Rules, Take Caution in Telling Patients
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses the importance of patient communication and disclosure surrounding possible measles exposure.
May 18, 2023, Medical Economics
Social Inflation Drives Up Malpractice Payouts—and Insurance Rates
Robert White, President of The Doctors Company and TDC Group, discusses the impact of social inflation on the medical malpractice industry.
June 10, 2022, Medscape
'My Malpractice Insurance Doubled!' Why, When Fewer Patients Are Suing?
Richard E. Anderson, MD, FACP, Chairman and Chief Executive Officer of The Doctors Company and TDC Group, is among those quoted on why severity is the reason premiums are up even though the number of claims is down.
Apr 01, 2022
Delay in Diagnosing Breast Cancer: A Case Summary and Tips to Reduce Risk
A delay in diagnosing breast cancer may result when a patient doesn’t follow through with diagnostic recommendations.
Agreements, Notices, Subscriber Agreement, and Power of Attorney
Apr 25, 2023
Nonadherent and Noncompliant Patients: Overcoming Barriers
Nonadherent or noncompliant patient conduct (whether intentional or inadvertent) can adversely affect clinical outcomes, undermine the practitioner-patient relationship, and disrupt the operation of practice.
Kathryn A. Bowen
Kathryn Bowen is the executive vice president of Madison Healthcare Insurance Services in Huntington Beach, California. She has been working in medical malpractice insurance for over 20 years.
Oct 19, 2023
Interventional Radiology Wrong-Site Procedure: Case Review
This case review explores factors contributing to a wrong-site procedure and highlights strategies that can help practitioners mitigate risk and increase safety.